Sep 30, 2021 | Legislation, News and Updates, Rulemaking
The Centers for Medicare & Medicaid Services (CMS) has released an interim final rule (IFR) establishing the independent dispute resolution (IDR) process for surprise billing disputes and a similar process for uninsured/self-pay patients, as required by the No...
Sep 22, 2021 | 340B, Litigation, News and Updates
The Health Resources and Services Administration (HRSA) has taken additional steps to require 340B drug discounts when drugs are dispensed through contract pharmacies. On September 22, HRSA followed up on earlier letters to six manufacturers refusing contract pharmacy...
Sep 10, 2021 | COVID-19, News and Updates
The Department of Health and Human Services (HHS) has announced the release of $25.5 billion in new COVID-19 funding for providers, including $17 billion to be distributed as Phase 4 of the Provider Relief Fund (PRF) and $8.5 billion in American Rescue Plan (ARP)...
Jul 19, 2021 | Medicare, Rulemaking
The Centers for Medicare & Medicaid Services (CMS) has released its proposed outpatient prospective payment system (OPPS) rule for calendar year 2022. To the disappointment of many in the hospital industry, the rule proposes to continue a pair of controversial...
Jul 13, 2021 | Medicare, Rulemaking
On July 13, 2021, the Centers for Medicare & Medicaid Services (CMS) released its proposed physician fee schedule rule for calendar year 2022, which includes provisions extending and expanding certain telehealth flexibilities, delaying the penalty phase of the...
Jun 18, 2021 | 340B, Litigation
The Health and Resource Service Administration (HRSA) announced June 18, in connection with the ongoing AstraZeneca case, that is withdrawing its December 2020 contract pharmacy Advisory Opinion “to avoid confusion and unnecessary litigation.” Despite withdrawal of...
